Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone.

Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone. JAMA Cardiol. 2023 08 01; 8(8):732-741.

View in: PubMed

subject areas

Albuminuria
Cardiovascular Diseases
Diabetes Mellitus, Type 2
Heart Failure
Humans
Male
Middle Aged
Nutrition Surveys
Renal Insufficiency, Chronic
Risk Factors

authors with profiles

George Bakris